SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-16-135667
Filing Date
2016-08-01
Accepted
2016-08-01 13:40:33
Documents
1
Period of Report
2016-07-26
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K a16-15767_18k.htm 8-K 18196
  Complete submission text file 0001104659-16-135667.txt   19604
Mailing Address 699 BOYLSTON ST 8TH FLOOR BOSTON MA 02116
Business Address 699 BOYLSTON ST 8TH FLOOR BOSTON MA 02116 (617) 600-3497
EPIRUS Biopharmaceuticals, Inc. (Filer) CIK: 0001135906 (see all company filings)

IRS No.: 043514457 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51171 | Film No.: 161796735
SIC: 2834 Pharmaceutical Preparations